Denv Detect Ns1 Elisa Ifu Suppliers and Manufacturers

Product Details: Number of Reactions(Preps)/Kit : 96 Wells Brand : InBios Sample Material : Serum Format : Antigen Detection Incubation Time : 60+30+20+1 Cat No : DNS1-1 The DENV DetectTM NS1 ELISA is for the early detection of Dengue virus (DENV) NS1 antigen in human serum. This test is for the presumptive clinical laboratory diagnosis of Dengue virus infection. This assay is intended for use in patients with clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. Samples collected from patients within seven (7) days after the onset of clinical symptoms should be evaluated with this assay (day 0 â?? day 7). Negative results obtained with this test do not preclude the diagnosis of dengue and should not be used as the sole basis for treatment or other patient management decision. This assay is not FDA cleared or approved for testing blood or plasma donors. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. FDA Cleared & CE Marked Early NS1 antigen detection (within first 7 days onset of symptoms) Helps differentiate dengue from other flaviviruses that may cross react with dengue antibodies but not with the antigen High Sensitivity & Specificity: 86.6% PPA & 97.8% NPA with prospectively collected positive and negative confirmed clinical specimens Kit can be performed in parallel with InBiosâ?? FDA Cleared dengue IgM ELISA for presumptive diagnosis of acute or convalescent stage dengue virus.

Product Details: Number of Reactions(Preps)/Kit : 96 Wells Brand : InBios Sample Material : Serum Incubation Time: 60+60+60+5+10+1 Storage 2-8 C Cat No : DDMS-1 The DENV DetectTM IgM Capture ELISA is for the qualitative detection of IgM antibodies to DENV recombinant antigens in serum for the presumptive clinical laboratory diagnosis of Dengue virus infection. The assay is intended for use only in patients with clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. 1st Assay to Receive FDA Clearance. Performance thoroughly evaluated with clinically confirmed cases of dengue 1-4 serotypes. Excellent positive and negative agreement with WHO reference panel (>90%). Improves accuracy by monitoring background reactivity with a normal cell antigen. Employs a simple, one step ratio method of interpretation. CE Marked.

Product Details: Number of Reactions(Preps)/Kit : 96 Wells Brand : Abbott Product Type : Microplate Sample : Serum CAT. NO : 11EK50 The presence of circulating non-structural glycoprotein (NS1) indicates Viremia. If sufficient virus is present, NS1 can be detectable in a patientâ??s blood from day 0 to day 5 following disease onset. The detection of NS1 antigen is therefore useful as a test of early acute infection. â?¢ Early diagnosis of dengue infection High accuracy with all dengue serotypes (DEN1,2,3, and 4) Simple and easy to use: All necessary reagents included in the kit â?¢ Shelf life and storage temperature: 18 months from the date of manufacturing at 2-8 'C Performance: Sensitivity 93.3 % (87.4 - 96.6 %), Specificity 98.9 % (96.0 - 99.7 %)

Product Details: Number of Reactions(Preps)/Kit : 50T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 15 min Sample Type : Blood Country of Origin : Made in India STANDARD E Dengue NS1 Ag ELISA analyzes Dengue NS1 antigens in serum and plasma using enzyme linked immunosorbent assay. Simple and easy to use: All necessary reagents included in the kit Highest accuracy with all dengue serotypes(DEN1,2,3, and 4) Able to detect antigens in samples with high sensitivity and specificity Performance Sensitivity : 91.4% (181/198) / Specificity : 98.2% (221/225)

The Elisa Reader/Microplate Reader is a vital medical device for hospitals, facilitating precise diagnostics and research. This sophisticated equipment efficiently reads microplate assays, delivering accurate results for a wide range of tests. With its user-friendly interface and versatile software, it enables seamless data analysis. Its optical system ensures high sensitivity and a broad detection range, making it ideal for various assays. The compact design saves valuable lab space, while the robust construction ensures longevity. This indispensable tool is crucial for diagnosing diseases, monitoring treatment efficacy, and advancing medical research, making it an indispensable asset for any hospital's laboratory.

Covid detection rapid test IFU English/german/italian/french and Spanish. Price 1,25 Euro /unit for 3.000 units

Product Details: Quantity/Kit : 96 wells/Plate Format :Indirect Brand : InBios Incubation Time : 30 + 30 +10 + 1 Sample Type : Serum or dried blood spots Cat No : FILA-1 he Filaria DetectTM IgG4 ELISA is for qualitative detection of specific IgG4 antibodies in specimens to highlyspecific antigen IWb123 target antigen expressed primarily in infective stage larvae (L3) of the lymphatic-dwelling parasite Wuchereria bancrofti (Wb). This product is for research use only. Not for use in diagnostic procedures. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. For research purposes only.

General Information One-Step Dengue Rapid Test is to detect the NS1 antigens in serum, plasma or whole blood. Sensitivity : 99.9% , Specificity : 99.5% Specimen : Serum , Plasma and Whole Blood Reading Time : 10 min

General Information One-Step Dengue Rapid Test is to detect the NS1 antigens and IgG&IgM antibodies in human blood. Sensitivity : 99.9% Specificity : 99.5 % Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min

Intended use The one step dengue ns1 ag test is a rapid chromatographic immunoassay for the qualitative detection of dengue virus ns1 antigen in serum or plasma to aid in the diagnosis of dengue viral infection. Summary Dengue is transmitted by the bite of an aedes mosquito infected with any one of the four dengue viruses. It occurs in tropical and sub-tropical areas of the world. Symptoms appear 3-14 days after the infective bite. Dengue fever is a febrile illness that affects infants, young children and adults. Dengue haemorrhagic fever (fever, abdominal pain, vomiting, bleeding) is a potentially lethal complication, affecting mainly children. Early clinical diagnosis and careful clinical management by experienced physicians and nurses increase survival of patients. One step dengue ns1 ag test is a simple, visual qualitative test that detects dengue virus ns1 antigen in human serum or plasma. The test is based on immunochromatography and can give a result within 15 minutes.

INTENDED USE The One Step Dengue NS1 Ag Test is a rapid chromatographic immunoassay for the qualitative detection of dengue virus NS1 antigen in serum or plasma to aid in the diagnosis of Dengue viral infection. SUMMARY Dengue is transmitted by the bite of an Aedes mosquito infected with any one of the four dengue viruses. It occurs in tropical and sub-tropical areas of the world. Symptoms appear 3��14 days after the infective bite. Dengue fever is a febrile illness that affects infants, young children and adults. Dengue haemorrhagic fever (fever, abdominal pain, vomiting, bleeding) is a potentially lethal complication, affecting mainly children. Early clinical diagnosis and careful clinical management by experienced physicians and nurses increase survival of patients. One step Dengue NS1 Ag Test is a simple, visual qualitative test that detects dengue virus NS1 antigen in human serum or plasma. The test is based on immunochromatography and can give a result within 15 minutes. 25PCS/BOX

Product Details: Number of Reactions(Preps)/Kit :96 Wells Brand : InBios Sample Material : Serum Formet : Immunocapture Incubation Time : 30+30+30+10 Cat. No : CHKG-C CHIKjj Detect : IgG ELISA Kit The CHIKjj DetectTM IgG ELISA is designed for the qualitative detection of IgG antibodies present in human serum targeting chikungunya virus E2/E1 proteins. This test is for the presumptive clinical laboratory diagnosis of chikungunya virus infection. This assay is intended for use only in patients with clinical symptoms consistent with chikungunya infection. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. Key Features : Developed using a novel technology1 that outperforms traditional antigen preparations, resulting in highly sensitive detection of recent and past CHIKV infection. >90% Sensitivity and Specificity DENV Detect and CHIKjj Detect can be run in parallel for differential diagnosis. CE Marked Ordering : Cat No : CHKG-C Formet : Immunocapture Quantity : 96 wells/Plate Incubation Time : 30 + 30 + 5 + 10 + 1 Sample Type : Serum Storage : 2-8 Shelf Life : 12 months

Product Details: Number of Reactions(Preps)/Kit : 96 Wells Brand : InBios Sample Material : Serum Format : Immunocapture Incubation Time : 30+30+30+10 Cat No : CHKM-R The CHIKjj Detect IgM ELISA is designed for the qualitative detection of IgM antibodies present in human serum targeting Chikungunya virus E2/E1 proteins. This test is not intended to screen blood or blood components. This test is for research use only. Not for use in diagnostic procedures. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. Key Features : InBios chikungunya kits have been developed using a novel technology1 that outperforms traditional antigen preparations, resulting in highly sensitive detection of recent and past CHIKV infection. Excellent results in CDC evaluation of commercially available chikungunya IgM assays. Ordering: Cat No CHKM-R Formet Immunocapture Quantity 96 wells/Plate Incubation Time 30 + 30 + 5 + 10 Sample Type Serum Storage 2-8 Shelf Life 12 months

BOSON - Rapid SARS-CoV-2 Antigen Test - Pack of 5 Available at 0.75 EUR Plus VAT and Transport per test IFU - Swedish, Finissh, Norwagian, English, Danish Product Descirption : "A home test for the rapid qualitative detection of SARS-CoV-2 virus antigen in anterior nasal swabs from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 Performance Characteristics: Sample type: nasal swab Time to result: 15-20 min Sensitivity - 97.70% Specificity - 99.84% Accuracy - 98.97% UK MHRA - DHSC Approved for Self Test Approved in Germany, France, Italy, Belgium, Netherlands, Greece, Spain, Portugal. Layperson study statistics: 99.84% of non-professionals carried out the test without requiring assistance 99.82% of different types of results were interpreted correctly Test Kit Specifications: 5 Tests / Kit Catalog No.: 1N40C5-4 Kit Components: 5 Rapid SARS-CoV-2 Antigen Test Card (sealed foil pouch) 5 sterilized swabs 5 extraction tubes 5 sample extraction buffer IFU 1 tube stand Box / Carton Specifications : 5 Tests / Kit Box size - 202*60*37 mm Carton size - 42*42*33 cm Carton gross weight: 10 kg 500 tests (100 boxes) / carton" MOQ : 3000 FOB Price : Euro 1.03

The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples. HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.

INTENDED USE The Helicobacter-Pylori antigen rapid test kit (stool) is a rapid visual immunoassay for the qualitative detection of helicobacter pylori antigen in human stool specimens. This kit is used as an aid in the diagnosis of H. pylori infection. INTRODUCTION Helicobacter pylori (also known as Campylobacter pylori) as a spiral-shaped gram negative bacteria which infects the gastric mucosa. H. pylori to causes several gastro-enteric diseases such as non-ulcerous dyspepsia, gastric and duodenal ulcer, active gastritis and can even increase the risk of stomach adenocarcinoma. The epidemiologic study shows that more than 50% of the world's population is infected by H. pylori strains. Infection is more prevalent in developing countries. The lowest infection rate is 20%, and the highest infection rate can be 90% in developing countries. H. pylori strains is the major reason to cause chronic gastritis and gastric ulcers, 80%-90% chronic gastritis patients and 95%-100% gastric ulcers patients are infected by H. pylori strains. So the detection and treatment of H. pylori strains infection is very important. At present several invasive and non-invasive approaches are available to detect this infection state. Invasive methodologies require endoscopy of the gastric mucosa with histologic, cultural and urease investigation, which are expensive and require some time for diagnosis. Alternatively, non-invasive methods are available such as breath tests, which are extremely complicated and not highly selective, and classical ELISA and immunoblot assays. This Kit belongs to non-invasive approach.

Uncut Sheet Leishmania IgG/IgM Rapid Test Specimen:Whole Blood/ Serum/ Plasma INTENDED USE The Leishmania IgG/IgM Rapid Test is a lateral flow immunoassay for the qualitative detection of antibodies including IgG and IgM to the subspecies of the Leishmania donovani (L. donovani), the Visceral leishmaniasis causative protozoans in human serum or plasma. This test is intended to be used as a screening test and as an aid in the diagnosis of the disease of Visceral leishmaniasis. Any reactive specimen with the Leishmania IgG/IgM Rapid Test must be confirmed with alternative testing method(s). SUMMARY AND EXPLANATION OF THE TEST Visceral leishmaniasis, or Kala-azar, is a disseminated infection caused by several subspecies of the L. donovani. The disease is estimated by the World Health Organization (WHO) to affect approximately 12 million people in 88 countries1. It is transmitted to humans by bites of the Phlebotomus sandflies, which acquire infection from feeding on infected animals. Though it is a disease for poor countries, in Southern Europe, it has become the leading opportunistic infection in AIDS patients2-3. Identification of L. donovani organism from the blood, bone marrow, liver, lymph nodes or the spleen provides a definite means of diagnosis. However, these test methods are limited by the sampling method and the special instrument requirement. Serological detection of anti-L. donovani Ab is found to be an excellent marker for the infection of Visceral leishmaniasis. Tests used in clinic include: ELISA, fluorescent antibody and direct agglutination tests4-5. Recently, utilization of L. donovani specific protein in the test has improved the sensitivity and specificity dramatically6-7. The Leishmania IgG/IgM Rapid Test is a recombinant protein based serological test, which detects antibodies including IgG, IgM and IgA to the L. Donovani. This test provides a reliable result within 10 minutes without any instrumentation requirements.

Uncut Sheet Toxoplasma Gondii IgG/IgM Tri-Lines Rapid Test Specimen :Whold Blood/Serum/Plasma INTENDED USE The One Step TOXO IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Toxoplasma gondii in Whole Blood /Serum / Plasma to aid in the diagnosis of TOXO infection. Toxoplasma gondii is an obligate intracellular protozoan parasite with a worldwide distribution. Serological data indicates that approximately 30% of the population of most industrialized nations is chronically infected with the organism. A variety of serologic tests for antibodies to Toxoplasma gondii have been used as an aid in diagnosis of acute infection and to assess previous exposure to the organism. These tests are the Sabin-Feldman dye test, direct agglutination, indirect hemagglutination, latex agglutination, indirect immunofluorescence, and ELISA. Recently, lateral flow chromatographic immunoassay, such as The Toxo IgM/IgG Rapid Test (Whole Blood/Serum/Plasma) was introduced into the clinic for the serodiagnosis of Toxoplasma gondii infection. One step TOXO IgG/IgM Test is a simple, visual qualitative test that detects TOXO antibodies in human Whole Blood/serum/plasma. The test is based on immunochromatography and can give a result within 15 minutes. Storage and Stability Store as packaged in the sealed pouch at room temperature or refrigerated (4-30â?? or 40-86â??). The test device is stable through the expiration date printed on the sealed pouch. The test must remain in the sealed pouch until use.